The RED extract showed an optimal safety profile, and a significant reduction in TNF-α and other pro-inflammatory cytokines/chemokines, suggesting its potential use as adjuvant therapy to reduce symptoms and prevent relapses in Crohn’s disease patients [81,82]. This evidence concerns the gene TNF and Crohn disease.